| | Identification | Back Directory |  | [Name] 
 Caspase-3/7 Inhibitor I
 |  | [CAS] 
 220509-74-0
 |  | [Synonyms] 
 abs814634
 (S)-Caspase-3/7 Inhibitor I
 MMPSI, Caspase-3/7 Inhibitor I
 5-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]sulfonyl-1H-indole-2
 5-[(2S)-2-(METHOXYMETHYL)PYRROLIDIN-1-YL]SULFONYL-1H-INDOLE-2;3-DIONE
 1H-Indole-2,3-dione, 5-[[(2S)-2-(methoxymethyl)-1-pyrrolidinyl]sulfonyl]-
 Pyrrolidine,1-[(2,3-dihydro-2,3-dioxo-1H-indol-5-yl)sulfonyl]-2-(MethoxyMethyl)-,(2S)-
 |  | [Molecular Formula] 
 C14 H16 N2 O5 S
 |  | [MDL Number] 
 MFCD22581511
 |  | [MOL File] 
 220509-74-0.mol
 |  | [Molecular Weight] 
 324.35
 | 
 | Chemical Properties | Back Directory |  | [density ] 
 1.415±0.06 g/cm3(Predicted)
 |  | [storage temp. ] 
 Store at -20°C
 |  | [solubility ] 
 insoluble in H2O; ≥16.2 mg/mL in DMSO; ≥2.17 mg/mL in EtOH with gentle warming and ultrasonic
 |  | [form ] 
 solid
 |  | [pka] 
 8.66±0.20(Predicted)
 |  | [color ] 
 Light yellow to yellow
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 MMPSI is a potent and selective small molecule caspase 3 and caspase 7 inhibitor with an IC50 of 1.7 μM for human caspase-3. MMPSI can significantly reduce ischemia-reperfusion-induced infarct size in the isolated rabbit heart, and reduce apoptosis in both the ischemic myocardium and isolated cardiomyocytes. MMPSI can be used for researching cardioprotection[1].
 |  | [Biological Activity] 
 caspase-3/7 inbibitor i is a potent, reversible, isatin sulfonamide-based inhibitor of caspase-3 (ki(app) = 60 nm) and caspase-7 (ki(app) = 170 nm). is a weaker inhibitor of caspase-9 (ki(app) = 3.1 mm). it has only a trivial effect (ki(app) >25 mm) on the activities of caspase-1, caspase-2, caspase-4, caspase-6, and caspase-8. it has been shown to inhibit apoptosis in camptothecin treated jurkat cells (ic50 ~50 μm). also it has been reported to inhibit apoptosis in chondrocytes (44% inhibition at 10 μm and 98% inhibition at 50 μm). selectivity for caspases-3 and 7 involves unique hydrophobic residues in the s2 pocket surrounding the catalytic cysteine residue. [1] [2] in some systems inhibition of caspases-3 and -7 can prevent apoptosis and may therefore have important therapeutic implications. [3]a potent, cell-permeable, and specific, reversible inhibitor of caspase-3 (ki = 60 nm) and caspase-7 (ki = 170 nm).
 |  | [target] 
 Caspase-3
 |  | [IC 50] 
 human Caspase-3: 1.7 μM (IC50)
 |  | [storage] 
 Store at -20°C
 |  | [References] 
 1. lee, d., et al. 2001. j. med. chem. 44, 2015. 2. lee, d., et al. 2000. j. biol. chem. 275, 16007. 3. clements, k. m., burton‐wurster, n., nuttall, m. e., & lust, g. (2005). caspase‐3/7 inhibition alters cell morphology in mitomycin?\c treated chondrocytes. journal of cellular physiology, 205(1), 133-140.
 | 
 | 
                    
                        
                            | Company Name: | Merck KGaA |  
                            | Tel: | 21-20338288 |  
                            | Website: | www.sigmaaldrich.cn |  |